CD47 and neoplasm: To investigate whether CD47 is required for KRAS-driven tumor evasion from macrophage phagocytosis, we treated the KrasLSL-G12D/+p53fl/fl mice with Cd47 shRNA delivered by adeno-associated virus (AAV) along with intratracheal administration of adeno-Cre.